+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: AstraZeneca: Performance, Products, Pipeline and Potential

Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2025
  • 127 Pages
From
Arcturus Therapeutics Holdings Inc (ARCT) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Arcturus Therapeutics Holdings Inc (ARCT) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • April 2026
  • 56 Pages
From
Chronic Kidney Disease Medication Market - Global Forecast 2026-2032 - Product Thumbnail Image

Chronic Kidney Disease Medication Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 182 Pages
  • Global
From
Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 127 Pages
  • Global
From
Bioanalytical Testing Services Market Report Size, Share, Trends and Forecast by Molecule Type, Test Type, Workflow, and Region, 2025-2033 - Product Thumbnail Image

Bioanalytical Testing Services Market Report Size, Share, Trends and Forecast by Molecule Type, Test Type, Workflow, and Region, 2025-2033

  • Report
  • September 2025
  • 146 Pages
  • Global
From
Direct Acting Antivirals Market - Global Forecast 2026-2032 - Product Thumbnail Image

Direct Acting Antivirals Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • March 2026
  • 39 Pages
From
Novavax Inc (NVAX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Novavax Inc (NVAX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • September 2025
  • 60 Pages
From
Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • November 2025
  • 54 Pages
From
Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • April 2026
  • 40 Pages
From
Inhaled and Nasal Drug Delivery Device Market Strategic Analysis 2026-2031: Technology Transitions, Regional Dynamics, and Competitive Landscape - Product Thumbnail Image

Inhaled and Nasal Drug Delivery Device Market Strategic Analysis 2026-2031: Technology Transitions, Regional Dynamics, and Competitive Landscape

  • Report
  • February 2026
  • 99 Pages
  • Global
From
Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • July 2025
  • 59 Pages
From
Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2025
  • 66 Pages
From
Ionis Pharmaceuticals Inc (IONS) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Ionis Pharmaceuticals Inc (IONS) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • July 2025
  • 67 Pages
From
AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • March 2026
  • 57 Pages
From
Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035 - Product Thumbnail Image

Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035

  • Report
  • March 2026
  • 752 Pages
  • Global
From
Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • February 2026
  • 44 Pages
From
Seelos Therapeutics, Inc. (SEEL) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Seelos Therapeutics, Inc. (SEEL) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • October 2024
  • 41 Pages
From
MetaVia Inc (MTVA) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

MetaVia Inc (MTVA) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • December 2025
  • 49 Pages
From
Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • July 2025
  • 60 Pages
From
Loading Indicator